Cargando…
Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study
AIMS: Although coronavirus disease 2019 (COVID-19) and bacterial sepsis are distinct conditions, both are known to trigger endothelial dysfunction with corresponding microcirculatory impairment. The purpose of this study was to compare microvascular injury patterns and proteomic signatures in COVID-...
Autores principales: | Rovas, Alexandros, Buscher, Konrad, Osiaevi, Irina, Drost, Carolin Christina, Sackarnd, Jan, Tepasse, Phil-Robin, Fobker, Manfred, Kühn, Joachim, Braune, Stephan, Göbel, Ulrich, Thölking, Gerold, Gröschel, Andreas, Rossaint, Jan, Vink, Hans, Lukasz, Alexander, Pavenstädt, Hermann, Kümpers, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208353/ https://www.ncbi.nlm.nih.gov/pubmed/35723762 http://dx.doi.org/10.1007/s10456-022-09843-8 |
Ejemplares similares
-
Microvascular dysfunction in COVID-19: the MYSTIC study
por: Rovas, Alexandros, et al.
Publicado: (2020) -
Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study
por: Rovas, Alexandros, et al.
Publicado: (2021) -
Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit – the GlycoNurse study
por: Rovas, Alexandros, et al.
Publicado: (2018) -
Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study
por: Rovas, Alexandros, et al.
Publicado: (2023) -
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study
por: Drost, Carolin Christina, et al.
Publicado: (2022)